Slideshow
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
This slideshow reviews drug information for LENVIMA (lenvatinib), indicated for renal cell carcinoma (RCC).
Table of Contents
Slide 3: Indication, Dosage, and Administration
Slide 9: Use in Specific Populations
Slide 12: Clinical Pharmacology
Slide 16: Warnings and Precautions
Slide 22: Clinical Safety and Efficacy
Slide 28: Drug Storage and Supply
Slide 30: References